The tumor suppressive effect of miR-365 in esophageal squamous cell carcinoma was demonstrated in vivo and in vitro by identifying IGF1R as a target of miR-365, an important component of the PI3K-AKT/PKB pathway. This evidence concerns the gene IGF1R and neoplasm.